Navigation Links
Dong-A PharmTech Co., Ltd. Announces Start of Phase III Trials for Udenafil, Its New Erectile Dysfunction Drug Under Development
Date:11/4/2009

Levitra (Bayer/GSK).

About Dong-A PharmTech Co., Ltd.

Dong-A PharmTech is a late-stage pharmaceutical company incorporated in Korea, focused on the development and commercialization of udenafil worldwide excluding Korea.

Statements under the Private Securities Litigation Reform Act: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to FDA review and approval, product development and acceptance, manufacturing, competition, and/or other factors, which are outside the control of the Company.

    Contact:
                 Mr. Won Geun KIM
                 General Manager
                 Tel: +82 2 560 8008
                 Fax: + 82 2 563 6517
                 Email: wgkim@donga.co.kr

SOURCE Dong-A PharmTech Co. Ltd.


'/>"/>
SOURCE Dong-A PharmTech Co. Ltd.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil
2. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... medical expert internationally recognized as a leading authority ... last month to suspend Doug Barron for doping ... the medical condition hypogonadism and was ... and discriminatory." ,, Hypogonadism is the ... referred to informally as Low T . ...
(Date:12/15/2009)... Today,s New York Times ... Kidney Drugs Spurs Division," illustrates an internal renal ... patients continuing to be deprived of their life-saving ... limit. ,, As Congress is poised to approve ... lives of transplant kidney recipients, behind-the-scenes debate continues ...
(Date:12/15/2009)... NEW YORK, Dec. 15 ,, ... report is available in its catalogue: ,, ... and Market Forecasts to 2015 ,, ... - Pipeline Analysis and Market Forecasts to ... the industry analysis specialist,s new report, "Hepatitis ...
Breaking Medicine Technology:Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta 28R 29 4968 1New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta 28R 29 4968 2New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta 28R 29 4968 3New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta 28R 29 4968 4New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta 28R 29 4968 5New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta 28R 29 4968 6Instanyl sets new standard in management of breakthrough cancer pain 56898 1Instanyl sets new standard in management of breakthrough cancer pain 56898 2Matthew Sarad to Reverse Aging and Cure Cancer 13997 1Matthew Sarad to Reverse Aging and Cure Cancer 13997 2Matthew Sarad to Reverse Aging and Cure Cancer 13997 3Matthew Sarad to Reverse Aging and Cure Cancer 13997 4
... Peptide Vaccine Aims to Use Memory Imprint to Yield a ... ... Intellect Neurosciences,Inc. (OTC Bulletin Board: ILNS) a biopharmaceutical company ... of Alzheimer,s disease and related disorders, announced today,that Dr. Rachel ...
... Since Groundbreaking 2002 ... ... new study reveals that,coiling, a minimally invasive procedure to treat aneurysms ... after,initial treatment in those aneurysms considered "untouchable" by the,traditional surgical option. ...
Other Medicine Technology:Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology Conference 2Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology Conference 3New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 2New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 3
(Date:12/15/2009)... associated with lower dementia risk, research finds , , TUESDAY, ... leptin, a hormone that regulates appetite, may guard against ... or 15 years this may be one of many ... Alzheimer,s disease," said senior study author Dr. Sudha Seshadri, ... of Medicine. "Or it may be one of many ...
(Date:12/15/2009)... the CDC have released some sobering statistics concerning the parallel rise ... offer employers an effective means of combating this trend afflicting their ... ... -- Rates of diabetes are climbing across America due in large ... rise the American Diabetes Association has stated that the rate of ...
(Date:12/15/2009)... Dec. 15 Knowledge ... the pharmaceutical and bio-tech research market with ... Over the past 11 years CMR has ... Consulting Network (PCN®), which now includes 70,000 ... both primary care and hard-to-reach specialties. ...
(Date:12/15/2009)... Patient advocate Betsy McCaughey, Ph.D., will be ... doesn,t matter whether there,s a public option. The current ... - give government authority over how your doctor treats ... agenda by shifting billions of dollars from Medicare to ... local politicians." ,, Betsy McCaughey is the ...
(Date:12/15/2009)... Dec. 15 North American application activity ... November year-over-year, according to the MIB Life ... applications over the past three months have lifted ... of -1.6%, to flat at November,s close, -0.1%. ... interest in the benefits available from life insurance," ...
Breaking Medicine News(10 mins):Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3
... than Cox-1 drugs, like naproxen, study says , , MONDAY, ... heart attack that comes with the use of nonsteroidal ... related to the specific pain-causing molecule they act against, ... correlation between the degree of inhibition in vitro [in ...
... about HIV, a new study by researchers from UCLA, ... has found that two-thirds of families with an HIV-infected ... , The qualitative study is the first to interview ... an HIV-infected parent about their concerns over HIV transmission ...
... for Health Enhancement Systems Studies (CHESS) has been awarded ... a division of the National Institutes of Health (NIH), ... communication research. , The five-year, $8.6 million grant for ... (CECCR II) will investigate problems associated with cancer communication ...
... 2008 increases 32% to $16.0 million. - Heart valve therapy products revenue rises ... surgical ablation products revenue grows 21.7%. - Third quarter gross ... its 2008 revenue guidance to $65 - $66 ... million., MINNEAPOLIS, ...
... might trigger genetic vulnerability , , MONDAY, Nov. 3 ... the United States that get a lot of precipitation ... a new study suggests. , Because these children may ... in the atmosphere to the ground, they might be ...
... U.S. Government Assistance Now $2.5 Million --, WASHINGTON, ... for International Development (USAID), is providing,an additional $1.5 million ... in Balochistan province in Pakistan. This brings the,total USAID ... USAID committed $1 million of the $2.5 million to ...
Other Medicine News:Health News:Study Sheds Light on Painkillers' Heart Risk 2Health News:Study Sheds Light on Painkillers' Heart Risk 3Health News:Study finds fears of HIV transmission in families with infected parent 2Health News:Center for Health Enhancement Systems Studies awarded $8.6 million NIH grant 2Health News:ATS Medical Announces Third Quarter Results 2Health News:ATS Medical Announces Third Quarter Results 3Health News:ATS Medical Announces Third Quarter Results 4Health News:ATS Medical Announces Third Quarter Results 5Health News:ATS Medical Announces Third Quarter Results 6Health News:ATS Medical Announces Third Quarter Results 7Health News:ATS Medical Announces Third Quarter Results 8Health News:Rainier Spots Show Higher Autism Rates 2Health News:Rainier Spots Show Higher Autism Rates 3Health News:Rainier Spots Show Higher Autism Rates 4Health News:USAID Sends Additional Earthquake Assistance and Team of Experts to Pakistan 2
... Mobile space saver, very powerful, high ... analog controls, large bright digital display, ... pendulum system), guard barrier, dual lid ... motor, tough steel casing with chemical-resistant, ...
The Spinchron 15 centrifuge provides all the versatility and high capacity needed for today's full-service clinical lab needs. This centrifuge is available in a nonrefrigerated model with a speed up ...
... with a simple click of the ... the mouse cursor to the desired ... the slide and the magnified image ... User Interface (GUI) enables one-click operation ...
The simplest, neatest, most efficient anti-theft system for frames and sunwear. Available in 3 colors Black, Matte aluminum, and Bronze. Fits with any style or color of furniture. Safe, simple, easy...
Medicine Products: